Katrien Soleme BSc

Katrien Soleme, Director and Head of Safety Agreements, UCB Pharma SA, started her career in Drug Safety Pharmacovigilance more than 13 years ago and gained experience by working at Covance (CRO), Bristol-Myers Squibb and Tibotec (J&J). Katrien’s past experience focused on assuring that the required quality and compliance for PV projects and processes were met. Katrien joined UCB in June 2010 in the PV QA department and transferred to her current role in May 2012. She is passionate about patients’ safety and aims to drive quality into PV activities by providing direct support to areas impacted by GVP.